Aviva reported a 9% increase in general insurance premiums in the first quarter of 2025 (Q1 2025), reaching £2.9bn, up from £2.7bn in the same quarter of the previous year. Its UK and Ireland general insurance (UK&I GI) segment saw premiums increase by 12% to £2bn ($2.6bn), with an 8% rise in personal lines and 15% growth in commercial lines. According to the company, this growth reflects “strong new business and the acquisition of Probitas”. In Canada, general insurance premiums remained flat at £900m (C$1.68bn) in reported currency basis and up 5% on constant currency basis, with personal lines posting a 10% rise due to pricing strategies. Commercial lines witnessed a 2% decline as the company maintained its focus on “margins over volume”. The company’s retirement division sales also increased by 4% to £1.8bn, driven by individual annuities and equity release. Its protection and health sales rose by 19% to £126m following the completion of an acquisition from AIG in April 2024. Health in-force premiums increased by 11%. The insurer's wealth net flows reached £2.3bn in Q1 2025 as against £2.7bn in Q1 2024, representing 5% of opening assets under management. Additionally, Aviva stated that estimated Solvency II shareholder cover ratio remains at 201%, compared with 203% in the prior year. Aviva stated that it is already a more capital-light business, which accounts for 56% of operating profit, and the acquisition of Direct Line is expected to take this figure to beyond 70% as synergies and profits are delivered. Expressing confidence in meeting its targets, the company aims to achieve an operating profit of £2bn by 2026, Solvency II OFG of £1.8bn by 2026 and cash remittances of more than £5.8bn cumulative for 2024–26. Aviva Group CEO Amanda Blanc said: “Aviva has got off to a great start in 2025. We continue to trade strongly, serving our customers well, growing profitably right across the group, and demonstrating the resilience of our diversified business in a period of market volatility. “We continue to be very positive about the outlook for 2025. Our balance sheet is strong, we have a clear customer-focused strategy, which we continue to deliver at pace, and our market-leading businesses are growing well, especially in capital-light areas. We are increasingly confident about Aviva’s prospects and meeting our financial targets.” Blanc further added: “The acquisition of Direct Line is firmly on track. Direct Line shareholders voted overwhelmingly in favour of the transaction and we expect to complete the deal in the middle of the year.” Story Continues Recently, the UK’s Competition and Markets Authority launched an investigation into Aviva's proposed £3.7bn acquisition of Direct Line, examining its potential effects on competition within the UK market. "Aviva posts 9% rise in general insurance premiums in Q1 2025 " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. View Comments
Aviva posts 9% rise in general insurance premiums in Q1 2025
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...